Literature DB >> 23615754

Effect of insurance payer status on the surgical treatment of early stage breast cancer: data analysis from a single health system.

Linda Adepoju1, Stephen Wanjiku, Megan Brown, Weikai Qu, Mallory Williams, Roberta E Redfern, Joseph J Sferra.   

Abstract

The effect of insurance payer status on surgical treatment of early stage breast cancer is unclear. This retrospective study examined the effect of insurance payer on mastectomy rates of 1539 women treated within a single health system. Women with Medicaid had significantly larger tumors compared with those with private insurance (PI) at diagnosis (3.3 cm vs 2.1 cm, P < .05) and were more likely to be treated with mastectomy for larger tumors compared with women with PI. However, women with PI were more likely to have mastectomy for smaller tumors; among women with tumors less than 2 cm, 11% with Medicaid underwent mastectomy compared with 47% with PI (P < .05). Overall, when compared with those with PI, women with Medicaid were more likely to receive mastectomy (60% vs 39%, P < .05).

Entities:  

Mesh:

Year:  2013        PMID: 23615754     DOI: 10.1001/jamasurg.2013.61

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  4 in total

1.  Racial and socio-economic disparities in breast cancer hospitalization outcomes by insurance status.

Authors:  Tomi Akinyemiju; Swati Sakhuja; Neomi Vin-Raviv
Journal:  Cancer Epidemiol       Date:  2016-07-07       Impact factor: 2.984

2.  Impact of Medicaid Expansion on Cardiac Surgery Volume and Outcomes.

Authors:  Eric J Charles; Lily E Johnston; Morley A Herbert; J Hunter Mehaffey; Kenan W Yount; Donald S Likosky; Patricia F Theurer; Clifford E Fonner; Jeffrey B Rich; Alan M Speir; Gorav Ailawadi; Richard L Prager; Irving L Kron
Journal:  Ann Thorac Surg       Date:  2017-05-26       Impact factor: 4.330

3.  Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012.

Authors:  Mary C Schroeder; Charles F Lynch; Taher Abu-Hejleh; Elizabeth A Chrischilles; Alexandra Thomas
Journal:  Clin Breast Cancer       Date:  2014-08-18       Impact factor: 3.225

4.  Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis.

Authors:  Min Wu; Peng Lu; Luwen Shi; Shao Li
Journal:  Oncotarget       Date:  2015-11-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.